Molecular Neurodegeneration (2023) 18:41
The original article [1] contained errors in the Funding section. The correct Funding information can be viewed ahead:
Funding
This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Ministry of Science, ICT and Future Planning (MSIP) (NRF-2020R1A5A1019023 to Y.T.K., NRF-2021R1A2B5B03002614 to Y.T.K., NRF-2020R1A5A1019023 to Y.H.S., and NRF-2022R1A2C1004913 to Y.H.S.), the Korea Dementia Research Project (HU21C0071 to Y.H.S.), and the Ministry of Education (RS-2023-00243474 to E.J.B.). This work was also supported by Korea Drug Development Fund (KDDF) (RS-2022-00166787 to K.W.S.).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13024-023-00630-7.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Lee, J., Sung, K.W., Bae, EJ. et al. Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology. Mol Neurodegeneration 18, 69 (2023). https://doi.org/10.1186/s13024-023-00661-0
Published:
DOI: https://doi.org/10.1186/s13024-023-00661-0